Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial
安罗替尼联合托瑞普利单抗作为一线治疗方案用于体能状态评分为 2 的晚期胃癌患者:II 期 APICAL-GC 试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-60317-z
Liu, Ke; Qin, Bao-Dong; Chen, Shi-Qi; Zhong, Xue; Duan, Xiao-Peng; Wu, Ying; Wang, Zhan; Ling, Yan; Sun, Li; Ye, Chen-Yang; Shi, Dong-Min; Gao, Ning; Jiao, Xiao-Dong; Zang, Yuan-Sheng